Dr. Jody Platt. She is an Associate Professor of Learning Health Sciences at the University of Michigan Medical School. Trained in medical sociology and health policy, her research focuses on issues at the intersection of informatics and ethics. She is interested in understanding what makes data-driven health trusted, and the pathways for earning, achieving, and sustaining trust across stakeholders. Dr. Platt is the Academy Health and ABIM Foundation Senior Scholar in Residence advising on issues of measuring and building trust.

When M4 Ahmad Hider crosses the stage at Hill Auditorium this week to receive his diploma and officially become Dr. Hider, like his fellow graduates he is excited about the future that awaits him in residency and beyond. As Hider becomes more fully immersed in the health care system, however, he also feels that many things need fixing. So, when he begins a residency in general surgery at University of Colorado Anschutz Medical Campus, he is preparing to for a dual role — becoming the best surgeon he can, and improving health care for patients.

Building a comprehensive human kidney cell and tissue catalog could help develop more treatments for kidney disease.

Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment

A survey focused on how much people in their teens and early 20s know about periods and their experience and attitudes around “period poverty”.

Researchers improved memory and reduced neuroinflammation in a mouse model of Alzheimer’s Disease, suggesting another avenue for potential treatment.

Buprenorphine prescribing for opioid addiction used to require a special waiver from the federal government, but a new study shows what happened in the first year after that requirement was lifted.

Researchers have used advanced computer algorithms to uncover distinct molecular subgroups of kidney diseases, independent of clinical classifications. These findings have significant implications for personalized treatment approaches.

The Clinical Trials Support Office (CTSO) is pleased to announce that Mio Nakamura, MD, MS, Clinical Assistant Professor, Dermatology, has been appointed as the new Associate Medical Director of the Michigan Clinical Trials Support Unit (M-CTSU) and Michigan Clinical Research Unit (MCRU). Dr. Nakamura’s appointment will begin July 1, 2024, and is a 2-year term.

Overuse of antibiotics can lead bacteria to evolve antimicrobial resistance, but Americans are still receiving the drugs for many conditions that they can’t treat.

Four with Medical School ties are among 12 University of Michigan faculty and staff members recognized by the American Association for the Advancement of Science (AAAS) as 2023 fellows in recognition of their extraordinary achievements.

The number of patients using cannabis for medical purposes has increased more than 600 percent since 2016.

A new urine-based test addresses a major problem in prostate cancer: how to separate the slow growing form of the disease unlikely to cause harm from more aggressive cancer that needs immediate treatment.

Researchers recently revealed a new mechanism behind antiphospholipid syndrome that the investigators hope will eventually allow treatments to be targeted closer to the source of the problem.

Data on medical cannabis use found that enrollment in medical cannabis programs increased overall between 2016 and 2022, but enrollment in states where nonmedical use of cannabis became legal saw a decrease in enrollment